Cover and table of contents

6K characters. Original on sec.gov · Markdown

Cover and table of contents

​

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

​

FORM 10-Q

(Mark One)

​

​​​
☒​QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
​​​
​​For the quarterly period ended June 30, 2023 ​ OR
​​​
☐​TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

​

For the transition period from to

​

Commission file number: 1-10879

​

Graphic

AMPHENOL CORPORATION

(Exact name of Registrant as specified in its charter)

​​
Delaware22-2785165
(State or other jurisdiction of incorporation or organization)(I.R.S. Employer Identification No.)

​

358 Hall Avenue

Wallingford**,** Connecticut 06492

(Address of principal executive offices) (Zip Code)

​

203**-**265-8900

(Registrant’s telephone number, including area code)

​

Securities registered pursuant to Section 12(b) of the Act:

​

​​​
​​​
Title of each classTrading Symbol(s)Name of each exchange on which registered
Class A Common Stock, $0.001 par valueAPHNew York Stock Exchange

​

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ⌧ No ◻

​

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ⌧ No ◻

​

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

​

​​
Large Accelerated Filer ☒Accelerated Filer ☐
​​
Non-accelerated Filer ☐Smaller Reporting Company ☐ ​
​Emerging Growth Company ☐

​

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

​

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

​

As of July 25, 2023, the total number of shares outstanding of the Registrant’s Class A Common Stock was 596,453,955.

​

​

​

Amphenol Corporation

Index to Quarterly Report

on Form 10-Q

​

​​Page
​​​​
Part I​Financial Information​
​​​​
Item 1.​Financial Statements (unaudited):​
​​​​
​​Condensed Consolidated Balance Sheets as of June 30, 2023 and December 31, 20222
​​​​
​​Condensed Consolidated Statements of Income for the Three and Six Months Ended June 30, 2023 and 20223
​​​​
​​Condensed Consolidated Statements of Comprehensive Income for the Three and Six Months Ended June 30, 2023 and 20224
​​​​
​​Condensed Consolidated Statements of Cash Flow for the Six Months Ended June 30, 2023 and 20225
​​​​
​​Notes to Condensed Consolidated Financial Statements6
​​​​
Item 2.​Management’s Discussion and Analysis of Financial Condition and Results of Operations24
​​​​
Item 3.​Quantitative and Qualitative Disclosures About Market Risk39
​​​​
Item 4.​Controls and Procedures39
​​​​
Part II​Other Information​
​​​​
Item 1.​Legal Proceedings40
​​​​
Item 1A.​Risk Factors40
​​​​
Item 2.​Unregistered Sales of Equity Securities and Use of Proceeds40
​​​​
Item 3.​Defaults Upon Senior Securities40
​​​​
Item 4.​Mine Safety Disclosures40
​​​​
Item 5.​Other Information40
​​​​
Item 6.​Exhibits41
​​​​
Signature​​44

​

​

​

PART I — FINANCIAL INFORMATION

​

Next: Item 1. Financial Statements